Wole M. Fayemi wole.mo.fayemi@gmail.com:

Cell: 718 644 6500 OBJECTIVE: To re-establish myself as one of the most respected analysts in the automotive, technology, software, services, semiconductor, new media, publishing, suppliers, global parts, commodities, petrochemical, oil/energy services, refining, petrochemical, pharmaceutical, biotechnology and specialty drug sectors of the healthcare industry, contributing my skills, experience and contacts to be leveraged in a team setting, for an institution containing sufficient assets, resources and human/intellectual capital to best exploit them. KEY ACCOMPLISHMENTS: Ranked #1 by the Greenwich AssociatesPoll as a sell side biotechnology analyst in 1993. Ranked #4 by Zack’s/Wall Street Journal as a sell side biotechnology analyst in 1996. RELEVANT PROFESSIONAL EXPERIENCE Motorious, Inc. Irvine, CA September 1998 to ‘Present’ Founder, Chief Strategic Officer, Acting CEO: Formed and incorporated Motorious Motors, a research & development LLC in 1997, and Motorious, Inc., a holding company in 1999. Provided seed funding of $1MM for Series A and raised Series B private round. Through SEMA: The Specialty Equipment Marketing Organization, an industry trade group, met with other companies in the industry (automotive OEMs, Tier 1 suppliers, parts suppliers, warehouse distributors, independent jobbers) regarding a plan to consolidate and roll-up distribution of the $30 billion U.S aftermarket for customizing automobiles, with a primary focus on the three tiers of the used car market. Composed and filed U.S. Patent Application Number 09/854,347: System and Method of Creating and Assembling Mass Customized Multi-Component Articles in 2002 and prosecuted method patent until 2008. Created a manufacturing assembly, distribution and consumer retail brand franchise plan, based upon the basic tenets of large scale game theory. Cruttenden Roth Newport Beach, CA September 1996 to September 1998 Senior VP, Senior Research Analyst: Expanded the firm’s visibility and presence in healthcare. Cultivated and trained two associates to become junior analysts. Broadened industry coverage and expertise to include oncology and hematology. Conceived, planned and executed the first 3 day healthcare conference for the firm in 1997. Organized dinners and private meetings, and presided as chair of the conference. Drafted and delivered the Keynote Address speech. Published Industry Report: Cashing In On Cancer: An Analysis of the Shifting Fundamentals of the Sector. Genesis Merchant Group Securities San Francisco, CA March, 1995 to September, 1996 Principal, Senior Research Analyst: Brought on as principal to build a healthcare banking/research group within a boutique firm. Hired a team of three associates and support staff. Instrumental in securing investment banking business in the form of three public secondary transactions and four private placements. Published seminal industry reports highlighting between 30 and 75 companies, both pubic and private, while formally covering approximately 20 publicly traded companies.: The Investors’ Roadmap to Profiting from the Genomics Revolution (profiled on CNBC as a pundit following article in Barron’s) and Going For Broke: Orthopedics and Biomaterials in the 21st Century. Hambrecht & Quist (JP Morgan Chase H&Q) New York, NY August 1991 to August 1994 Senior Research Analyst: Promotion included expansion of responsibilities to corporate finance transactions. Primarily responsible for scientific and technical due diligence, and instrumental in some cases in winning investment banking business, based upon proven track record and buy side following. Broadened the number of companies under formal coverage. Published first industry report entitled Buy-O-Tech™. Research Analyst: Responsible for maintaining and expanding the universe of stocks covered by previous analyst. Attended medical and basic science conferences (ACC, AHA, ASCO, ICCAC), cultivated sources in the industry and at the FDA. Published both company reports and industry reports. Followed and published on approximately ten companies. Research Associate: Hired to support one of the top ranking biotechnology analysts. Responsible for creating and maintaining databases on companies in the industry, building and updating financial models and projections, and researching product development data in peer review journals: New England Journal of Medicine, Journal of the American Medical Association, Science, Nature, Lancet. Ghost authored morning call notes, and co-authored several company reports. EDUCATION: Harvard College Cambridge, MA AB: Bachelor of Arts, June 1991. Biomedical Engineering/Applied Mathematics. Member, Spee Club. Varsity Swim Team. Varsity Croquet Team.